Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nicholas Lamparella"'
Publikováno v:
Rare Tumors, Vol 5, Iss 3, Pp e46-e46 (2013)
Epithelioid angiomyolipomas (EAMLs) are rare mesenchymal tumors whose malignant variant is extremely uncommon and highly aggressive. Treatment strategies include chemoradiation, transcatheter arterial embolization and surgical resection, which has re
Externí odkaz:
https://doaj.org/article/e8f95f7ac53b4fd08c237d9d2b36f4b2
Autor:
Elaine M Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S Ross, Pedram Razavi, Shanu Modi, Neil M Iyengar, Rachel Sanford, Tiffany Troso-Sandoval, Mila Gorsky, Jackie Bromberg, Pamela Drullinsky, Diana Lake, Serena Wong, Patricia DeFusco, Nicholas Lamparella, Ranja Gupta, Tasmila Tabassum, Leigh Ann Boyle, Artavazd Arumov, Tiffany A Traina
Publikováno v:
Cancer Research. 82:P1-14
Background: Chemotherapy remains the mainstay of treatment for early-stage triple negative breast cancer (TNBC), yet targetable drivers of interest are under investigation. A subset of TNBCs express the androgen receptor (AR) and exhibit androgen-dep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c13cb51455eb77d7eedf06d84d46453
https://doi.org/10.1158/1538-7445.sabcs21-p1-14-03
https://doi.org/10.1158/1538-7445.sabcs21-p1-14-03
Autor:
Elaine M. Walsh, Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S. Ross, Pedram Razavi, Shanu Modi, Neil M. Iyengar, Rachel Sanford, Tiffany Troso-Sandoval, Mila Gorsky, Jacqueline Bromberg, Pamela Drullinsky, Diana Lake, Serena Wong, Patricia Ann DeFusco, Nicholas Lamparella, Ranja Gupta, Tasmila Tabassum, Leigh Ann Boyle, Artavazd Arumov, Tiffany A. Traina
Publikováno v:
Breast cancer research and treatment. 195(3)
Chemotherapy with or without immunotherapy remains the mainstay of treatment for triple-negative breast cancer (TNBC). A subset of TNBCs express the androgen receptor (AR), representing a potential new therapeutic target. This study assessed the feas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e2e3c8d641ff0c1453658b5161f94ac
https://pubmed.ncbi.nlm.nih.gov/35986801
https://pubmed.ncbi.nlm.nih.gov/35986801
Autor:
Patricia DeFusco, Tiffany A. Traina, Ayca Gucalp, Nicholas Lamparella, Mark E. Robson, Tina Alano, Victoria S. Blinder, Sujata Patil, Jessica M. Scott, Artavazd Arumov, Leigh Ann Boyle, Lee W. Jones
Publikováno v:
Cancer Research. 80:P5-12
BACKGROUND: A subset of TNBC expresses a luminal signature and demonstrates AR-dependence. Enzalutamide (ENZA), an AR-antagonist, has activity with metastatic AR+ TNBC, with a clinical benefit rate of 33% (Traina et al, JCO 2018). We recently demonst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb9ef567198ca24ce54a3cddc491ce31
https://doi.org/10.1158/1538-7445.sabcs19-p5-12-09
https://doi.org/10.1158/1538-7445.sabcs19-p5-12-09
Autor:
Rachel Ann Sanford, Artavazd Arumov, Patricia DeFusco, Leigh Ann Boyle, Ayca Gucalp, Marcia Edelweiss, Shanu Modi, Tiffany A. Traina, Sujata Patil, Nicholas Lamparella, Mila Gorsky
Publikováno v:
Journal of Clinical Oncology. 37:546-546
546 Background: A subset of TNBC is dependent on AR signaling. Enzalutamide (ENZA), an AR-antagonist, has activity in patients (pts) with metastatic AR+ TNBC, with a clinical benefit rate of 33%. This study tests the feasibility of adjuvant ENZA for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3999c1dbd5f1cd432c364d5eea39e99d
https://doi.org/10.1200/jco.2019.37.15_suppl.546
https://doi.org/10.1200/jco.2019.37.15_suppl.546
Publikováno v:
The American Journal of Case Reports
Patient: Female, 55 Final Diagnosis: Mantle cell lymphoma Symptoms: Cytokine release syndrome • hypoglycemia • hypotension • splenic rupture • splenomegaly • vision loss Medication: — Clinical Procedure: Case Report Specialty: Oncology Ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ea97b87a7926b8bb66bea5cb632b79
https://pubmed.ncbi.nlm.nih.gov/26972227
https://pubmed.ncbi.nlm.nih.gov/26972227
Publikováno v:
Advances in experimental medicine and biology. 779
Non-small cell lung cancer represents a group of heterogeneous diseases. The last decade witnessed significant progress in improving our understanding of the biology of non-small cell lung cancer, which led to the identification of several genetic ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4453e60e19704eef808e9f3815f8fbd0
https://pubmed.ncbi.nlm.nih.gov/23288638
https://pubmed.ncbi.nlm.nih.gov/23288638
Autor:
Elizabeth M. Matthew, Lanlan Zhou, Zhaohai Yang, Nicholas Lamparella, Yingqiu Y. Liu, David T. Dicker, Wafik S. El-Deiry
Publikováno v:
Cancer Research. 72:3625-3625
Metastasis is responsible for the majority of cancer-related deaths. A limiting step in metastasis is access to circulation, thus circulating tumor cells (CTCs) should be present in all patients with metastatic tumors, which may have both diagnostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8edff7ac7d19ae90b9657eda02cbfb03
https://doi.org/10.1158/1538-7445.am2012-3625
https://doi.org/10.1158/1538-7445.am2012-3625